Management of hepatitis C in patients with chronic kidney disease

Table 1 Studies on acute hepatitis C treatment in hemodialysis patients

Ref.	Süleymanlar et al[26] (1998)	Gürsoy et al[27] (2001)	Urbánek et al[28] (2004)	Al-Harbi et al[29] (2005)	Rocha et al[30](2007)	Engel et al[32](2007)	Liu et al[33](2010)	Ferreira et al[31] (2011)
n	3	36	18	9	23	10	35	26
Interferon type	IFN	IFN	IFN	IFN	IFN	PEG-IFN α2b	PEG-IFN α2a	IFN
								PEG-IFN α2a
Schedule	4.5 MU tiw	3 MU or	10 MU +	3 MU tiw	3 MU or	1 μg/kg qw	135 μgv qw	3 MU tiw
		6-10 MU tiw	3 MU tiw		6 MU tiw			or 135 μg qw
Duration	16 wk	12 wk	3 wk + 12 wk	12 wk	48 or 24 wk	24 wk	24 wk	48 wk
SVR	100%	39%	72%	67%	43%	40%	89%	54%

IFN: Interferon; PEG-IFN: Pegylated interferon; MU: Million units; tiw: Three times a week; qw: Once a week; SVR: Sustained virological response rate by intention-to-treat analysis.